Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of the Philippine Medical Association ; : 0-2.
Article Dans Anglais | WPRIM | ID: wpr-963019

Résumé

This paper presents drug trials with Niridazole, an oral schistosomicide. Seventy-two of 106 patients who complemented treatment and who were followed-up monthly for 6 months gave a cure rate ranging from 48.3% to 84.8% and a highly satisfactory egg reduction in the stool of 96.3% to 98%. However, due to transient psychic side reactions observed in some patients, it is recommended that treatment with this drug be done under close medical supervision.(Auth. Abs.)

2.
Journal of the Philippine Medical Association ; : 0-2.
Article Dans Anglais | WPRIM | ID: wpr-963018

Résumé

A total of 10 adult patients suffering from early schistosomiasis japonica at the Bethany Hospital, Tacloban City with daily injections of Sodium Antimony Dimethylcysteine Tartrate (NaP) for 5 days at 400 mgs./day. Two had severe reactions consisting of nausea, vomiting and body weakness. Cardiac toxicity was observed in nine cases which developed reversible myocardial ischemic injury. A 100% cure rate from one to six months of stool follow-up after treatment was obtained. The exact value of this drug for mass treatment however, will depend on further evaluation of its toxicity and efficacy with a different dosage and/or schedule between injections.(Auth. Abs.)


Sujets)
Schistosoma japonicum
3.
Journal of the Philippine Medical Association ; : 0-2.
Article Dans Anglais | WPRIM | ID: wpr-963017

Résumé

In view of the absence thus far of a more effective and less toxic schistosomicide, a review and more thorough evaluation of the efficacy of stibophen was carried out. Three different schedules of treatment were tried wherein 10 and 15 injections were given every other day (Schedule I and II respectively) and 15 injections with 2 days interval between injections (Schedule III). A dose of 1 cc/10 kg. body weight per injection was used. Follow-up of the treated patients for a period of 6 months showed that Schedules II and III with mean cure rates of 66.4% and 53.4%, respectively, were better than Schedule I. Mild to moderate reactions occurred in majority of the patients treated with two having severe body weakness so that treatment had to be continued. Generally, less reactions were observed among children compared to adults. For the treatment of cases therefore, the use of 15 injections given either every other day or every fourth day is recommended especially among children 14 years and below.(Auth. Abs.)

SÉLECTION CITATIONS
Détails de la recherche